| 000 | 01507 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515043826.0 | ||
| 264 | 0 | _c20061208 | |
| 008 | 200612s 0 0 eng d | ||
| 022 | _a1533-4880 | ||
| 024 | 7 |
_a10.1166/jnn.2006.452 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMusumeci, T | |
| 245 | 0 | 0 |
_aLyoprotected nanosphere formulations for paclitaxel controlled delivery. _h[electronic resource] |
| 260 |
_bJournal of nanoscience and nanotechnology _c |
||
| 300 |
_a3118-25 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aChemistry, Pharmaceutical _xmethods |
| 650 | 0 | 4 |
_aCryoprotective Agents _xchemistry |
| 650 | 0 | 4 |
_aCrystallization _xmethods |
| 650 | 0 | 4 |
_aDelayed-Action Preparations _xchemistry |
| 650 | 0 | 4 | _aDiffusion |
| 650 | 0 | 4 |
_aFreeze Drying _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMaterials Testing |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 |
_aNanotubes _xchemistry |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 |
_aThyroid Neoplasms _xmetabolism |
| 700 | 1 | _aVicari, L | |
| 700 | 1 | _aVentura, C A | |
| 700 | 1 | _aGulisano, M | |
| 700 | 1 | _aPignatello, R | |
| 700 | 1 | _aPuglisi, G | |
| 773 | 0 |
_tJournal of nanoscience and nanotechnology _gvol. 6 _gno. 9-10 _gp. 3118-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1166/jnn.2006.452 _zAvailable from publisher's website |
| 999 |
_c16624084 _d16624084 |
||